Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial
Research output: Contribution to journal › Journal article › Research › peer-review
To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.
| Original language | English |
|---|---|
| Journal | Headache |
| Volume | 51 |
| Issue number | 1 |
| Pages (from-to) | 73-84 |
| Number of pages | 12 |
| ISSN | 0017-8748 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40140700